Hubei Goto Biopharm Co.,Ltd. (300966.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.26B
Enterprise Value3.38B
P/E Ratio-31.85
PEG Ratio0.44
Price/Sales Ratio4.41
Price/Book Ratio3.75
Enterprise/Revenue6.13
Enterprise/EBITDA414.27

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-0.13
Operating Margin-0.17
AD

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.11

Income Statement

Revenue606.18M
Revenue/Share5.83
Gross Profit83.5M
EBITDA57.93M
Net Income-73.36M
Diluted EPS-0.64

Balance Sheet

Total Cash108.43M
Total Cash/Share0.95
Total Debt1.25B
Total Debt/Equity1.62
Current Ratio1.04
Book Value Per Share7.46

Price History

52-Week Change10.21
52-Week High32.58
52-Week Low18.44
Moving Average 50 Days24.34
Moving Average 200 Days24.35

Statistics

Average Volume2.35M
Shares Outstanding115.28M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.05
Trailing Annual Dividend Yield0.18
Payout Ratio-0.33
Last Split FactorN/A
Last Split DateN/A
AD